期刊文献+

颈动脉粥样硬化病人血清免疫修饰低密度脂蛋白的测定及意义 被引量:2

The meaning of serum low density lipoprotein immune complexes assay in carotid atherosclerosis patients
下载PDF
导出
摘要 目的观察颈动脉粥样硬化(CAS)病人血清免疫修饰低密度脂蛋白(LDL—IC)含量的变化,说明LDL-IC与动脉粥样硬化(AS)的关系。方法通过复式超声确诊CAS病人78例,用酶联免疫吸附试验测定血清LDL-IC含量。结果CAS组血清LDL-IC含量为47.70士23.04AU;对照组为27.52土11.58AU。两组之间LDL-IC含量存在显著性差异(P<0.001)。结论LDL-IC与AS有密切关系。LDL-IC可反映体内各种化学修饰低密度脂蛋白的总情况。 Objective To observe the level of low density lipoprotein immune complexes (LDL-IC) incarotid atherosclerosis (CAS) patients. To explain the realtion between LDL-IC and atherosclerosis (AS).Methods Seventy-eight CAS patients were diagnosed by ultrasonic examination. The level of serum LDL-IC were assayed by enzyme linked immunosorbent assay. Results The level of serum LDL-IC was 47. 70±23.04 AU in CAS patients. The level of serum LDL-IC was 27. 52±11.58 AU in control subject. Thecontents of LDL-IC was significantly higher in CAS patients than in control subject (P<0.001 ).Conclusions There was a close realtion between LDL-IC and AS. The level of LDL-IC could representthe whole degree of all kinds of chemically modified low density lipoprotein in vivo.
出处 《脑与神经疾病杂志》 1999年第6期341-344,共4页 Journal of Brain and Nervous Diseases
关键词 颈动脉 动脉粥样硬化 免疫 低密度脂蛋白 carotid atherosclerosis immunity low density lipoprotein
  • 相关文献

同被引文献52

  • 1Davies M J, Richardson PD, Woolf N, et al. Risk of thrombosis in human atherosclerotic plague: role of extracellular lipid, macrophage, and smooth muscle cell content[ J ]. Br Heart J, 1993,69: 377-381.
  • 2Stemme S, Faber B, Holm J, et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein [ J ]. Proc Natl Acad Sci USA, 1995,92:3893 - 3897.
  • 3Wu R,Huang YH,Elinder LS,et al. Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL [ J ]. Arterioscler Thromb Vasc Biol, 1998, 18(4) :626 ~630.
  • 4Friedman P, Horkko S, Steinberg D, et al. Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol concentration [ J ]. J Biol Chem.2002,277(9) :7010 -7020.
  • 5Hasson GK. Regulation of immune mechanisms in atherosclerosis [ J ]. Ann NY Acad Sci,2001,947:157 -165.
  • 6Hansson GK. Immune mechanisms in atherosclerosis[ J]. Arterioscler Thromb Vasc Biol, 2001,21 ( 12 ): 1876 -1890.
  • 7Suzuki H,Kurihara Y,Takeya M,et al.A role for macrophages cavenger receptors inatherosclerosis andsusceptibility to infection [ J ]. Nature, 1997, 386(6622) :292 - 296.
  • 8Slivcrstein RL, Febbraio M. CD36 and atherosclerosis [ J ]. Curr Opin Lipid,2000,11:483 -489.
  • 9Febbraio M, Podrez EA, Smith JD, et al.Targeted disruption of the class B sc avenger receptor CD36 protects against atherosclerotic lesion development in mice[ J]. J Clin Invest ,2000,105:1049- 1056.
  • 10Shmaoka T,Kume N,Minami M,et al.Molecular cloning of a novel scavenger receptor for oxidized LDL, SR - PSOX,on macropnages [ J ]. J Biol Chem,2000,275:40663 - 40666.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部